Hemostasis effects of various glucose-lowering medications and angiopathy prevention
Aim. To assess hemostasis effects of various glucose-lowering medications (GLM), such as sulphanilamides, biguanides, and insulin, in regard to micro- and microangiopathy progression over 5 years in patients with Type 2 diabetes mellitus (DM-2). Material and methods. The study included 72 patients w...
Saved in:
| Main Authors: | G. G. Petrik, S. A. Pavlishchuk |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2011-06-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1833 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Haemostasiologic effects of various glucose-lowering medications in type 2 diabetes mellitus
by: G. G. Petrik, et al.
Published: (2010-04-01) -
Parameters of metabolism and hemostasis in patients with type 1 diabetes mellitus and microgiopathy of different severity
by: Galina Georgievna Petrik, et al.
Published: (2010-06-01) -
What’s the latest on sulphonylureas in the management of type 2 diabetes?
by: Gail Mkele
Published: (2013-12-01) -
Where do sulphonylureas fit in the type 2 diabetes guidelines?
by: Gail Mkele
Published: (2014-07-01) -
Russian Association of Endocrinologists reports commencement of Glimecomb clinical use
by: Editorial team Diabetes Mellitus
Published: (2011-12-01)